TB Alliance Provides Update on Progress in Ensuring Access to Pretomanid and BPaL-Based Regimens in BRICS Countries

15 January 2025

TB Alliance shared an update on progress in ensuring access to pretomanid and BPaL-based regimens in the five BRICS countries: South Africa, Brazil, India, Russia and China.

Full details about the approval and programmatic implementation milestones in the five countries, four of which are among the world’s ten highest drug-resistant TB burden countries, can be accessed here.

*BPaL regimen is comprised of bedaquiline, pretomanid and linezolid.

Source: TB Alliance